GL1X · GenesisL1 explorer

Research workbench

Human PARP14 (ARTD8), catalytic fragment in complex with an N-aryl piperazine inhibitor

Analyse Human PARP14 (ARTD8), catalytic fragment in complex with an N-aryl piperazine… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
5NQE
Type
protein
Length
360 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Poly [ADP-ribose] polymerase 14
EC
2.4.2.30
UniProt
Q460N5
Ligands
94Z
Pockets
1 · best druggability 0.71

Structure

x-ray diffraction · 1 distinct chain · 22% helix, 34% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BPoly [ADP-ribose] polymerase 14 (EC 2.4.2.30)protein18022% helix, 34% strandQ460N5

Ligands and binding sites

  • 94Z · 3-[[4-[4-(4-fluorophenyl)piperazin-1-yl]-4-oxidanylidene-butanoyl]amino]benzamide · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
18940.710.767694Z

Interfaces

1 interface between chains.

  • A–B · 175 Ų buried · 0 hydrogen bonds · protein-protein

Compared structures

  • 5NQE · Human PARP14 (ARTD8), catalytic fragment in complex with an N-aryl piperazine inhibitor · the same entry in another collection · chain A against A, TM-score 1.00
  • Q460N5 · AlphaFold monomer V2.0 prediction for protein mono-ADP- ribosyltransferase PARP14 (Q460N5) · a predicted model of the same protein · chain A against A, TM-score 0.95

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.